Parallel solid-phase synthesis of 3β-peptido-3α-hydroxy-5α-androstan-17-one derivatives for inhibition of type 3 17β-hydroxysteroid dehydrogenase

This publication has 26 references indexed in Scilit:

• Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: Oxidation/reduction and inhibition
  The Journal of Steroid Biochemistry and Molecular Biology, 2000
• 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes
  Journal of Molecular Endocrinology, 1999
• The use of testosterone as a male contraceptive
  Bailliere's Clinical Endocrinology and Metabolism, 1998
• The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
  Steroids, 1997
• Intracrinology: The Basis for the Rational Design of Endocrine Therapy at All Stages of Prostate Cancer
  European Urology, 1993
• Testicular 17β-hydroxysteroid dehydrogenase: Molecular properties and reaction mechanism
  Steroids, 1986
• Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
  Molecular and Cellular Endocrinology, 1986
• Inhibition of testosterone synthesis in the canine testis in vitro
  Contraception, 1983
• ANDROGEN PRODUCTION AND SKIN METABOLISM IN HIRSUTISM
  Journal of Endocrinology, 1977
• THE METABOLISM OF TESTOSTERONE BY HUMAN MALE SCALP SKIN
  Journal of Endocrinology, 1973